Chongqing Benlifang Medical Technology

Chongqing Benlifang Medical Technology is a high-tech medical enterprise based in Chongqing, China, specializing in the research, development, and production of advanced molecular diagnostic systems. The company focuses on digital PCR (dPCR) technology, providing high-sensitivity instruments and reagent kits for absolute nucleic acid quantification. Their flagship BLF-dPCR series is utilized in clinical and research settings for applications such as liquid biopsy, oncology mutation detection, and infectious disease monitoring. By integrating microfluidics and precision optics, Benlifang offers robust solutions for early cancer screening and personalized medicine. The company is recognized as a national high-tech enterprise and maintains a strong portfolio of intellectual property in the IVD sector. Benlifang aims to make high-end molecular diagnostics more accessible through localized innovation and manufacturing.